Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Vroege behandeling van COVID-19 met sotrovimab
okt 2021 | Pneumonie, Virale infecties